Cyclophosphamide independently improves daratumumab-mediated killing of MM cells by altering the tumor microenvironment to promote macrophage recruitment, polarization to a pro-inflammatory phenotype, and directing ADCP.Butein as a possible binder of human ACE2 receptor for interfering with SARS-CoV-2 entry: a computer-aided analysisThis warmth-sec